Cervical Precancerous Lesions Clinical Trial
Official title:
Optimal Timing for Performing Loop Electrosurgical Excision Procedure According to Different Menstrual Phase: Which is Best?
Cervical precancerous lesions (cervical intraepithelial neoplasia) are frequently diagnosed
and treated in women of reproductive-aged [1]. Loop electrosurgical excision procedure (LEEP)
is the standard surgical treatment in CIN 2 or 3 [1]. This procedure is an inexpensive, easy
to learn and provide specimens for pathological examination with the least major surgical
morbidity [2].
Although LEEP is a safe procedure, complications such as postoperative bleeding have been
reported. These haemorrhages make patients anxious, undergo unnecessary follow-ups,
additional procedures to stop bleeding and interfere in patients daily activities. Various
interventions have been attempted to prevent and/or reduce perioperative and/or postoperative
haemorrhage after LEEP including vasopressiın, tranexamic acid, Monsel's solution, or local
hemostats (TochoSil or Tisseel), but have failed to show a definite advantage over routine
practice [2-4].
A hormonal variation during the menstrual cycle is known to affect hemostasis [5] and the
blood flow of the genital organ [6,7]. A systematic review of the literature through PubMed,
OvidSP, Google Scholar, and Scopus identified only one previous investigation of menstrual
cycle period affect blood loss during the LEEP procedure. The authors showed that women had
less perioperative bleeding during the follicular phase than during the luteal phase [8]. Two
retrospective studies have also demonstrated rhinoplasty and mammoplasty caused more bleeding
during the luteal phase and menstruation than during the follicular phase [9,10]. In
contrast, other retrospective studies have shown no relation between operative blood loss and
the menstrual cycle for hysterectomy, myomectomy, and ovarian cystectomy [11-13] To answer
this clinically relevant question, the investigators performed a randomized study comparing
perioperative and postoperative bleeding between patients underwent LEEP procedure during the
follicular or luteal phase of the menstrual cycle.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT00923702 -
Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India
|
Phase 4 |